Legal and Policy Issues Currently Facing the Industry
Be a part of the discussions on pressing legal and policy challenges facing the industry. We will explore the critical role that 180-day exclusivity plays in accelerating patient access to generic medicines. This track will discuss the causes and potential policy solutions to prevent and mitigate drug shortages. This track also will share important updates on the CARES Act and discuss the impact of the Omnibus Bill on the generics industry. Finally, this track also will address Q1/Q2 assessments in the product development phase of ANDAs.